European Pharmaceutical Review

OCTOBER 7, 2022

Slow-release formulations were a popular choice for manufacturers, as these varieties reduce the traditional dosage frequency for patients, who only need to take these medications say, once a week. This is especially beneficial as a way of decreasing potential side effects.

Manufacturing 98

Manufacturing Marketing Side effects Transportation 98

pharmaphorum

JULY 29, 2022

Patients with end-stage renal disease (ESRD) who are on dialysis often need to be treated with anticoagulants to prevent blood clots, but as a result, can experience bleeding side effects. Now, Ionis and Bayer think they have a new drug that could sidestep that risk.

Side effects 72

Side effects FDA Pharma Patients 72

Pharmaceutical Technology

AUGUST 26, 2022

This guidance is in line with the WHO’s End TB Strategy, which aims for an 80% fall in worldwide TB incidence and a 90% decrease in TB deaths by 2030, compared with 2015. Each trial will recruit approximately 500 patients. Following this, patients must receive follow-ups to ensure that they do not have a post-treatment relapse.

Side effects 98

Side effects Pharmaceutical Patients Recruitment 98

European Pharmaceutical Review

DECEMBER 14, 2023

They also include many of the common “exclusions” in RCTs, such as pregnant women, children, the elderly and patients on multiple medications. million patients were registered with GP practices in England, which hold health information about each person “from the cradle to the grave”. As of October 2023, 62.93 EMA/95098/2010.

Medicine 116

Medicine Safety Competition Medical 116

European Pharmaceutical Review

SEPTEMBER 5, 2024

Cancer-associated fibroblasts, and their effects of the immune activity in the tumour, are considered one of the main reasons why around four out of five patients do not benefit from immunotherapies such as checkpoint inhibitors. For the 28 patients who received only pembrolizumab, the OS was 58 percent. 2015; 23(5):358–74.

Medicine 59

Medicine Side effects Marketing Patients 59

Pharmaceutical Technology

JULY 23, 2008

It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler.

Side effects 40

Side effects Marketing Pharmaceutical Sales 40

pharmaphorum

DECEMBER 15, 2022

Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Despite the slap on the wrist, the campaign was highly effective and there is no sign of this approach going away. Connecting peers.

Media 103

Media Healthcare Healthcare Education 103

Pharmaceutical Technology

OCTOBER 10, 2022

The company is aiming to enrol the first patient in the ALETTA Phase III trial in Q1 or Q2 of 2023, says Dr. Jan van der Mooren, Freya’s chief medical officer (CMO). Moreover, despite the buzz generated when Addyi was launched in 2015, only one other drug has since been marketed. But these treatments have their own limits.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Impetus Digital

JANUARY 3, 2023

Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Despite the slap on the wrist, the campaign was highly effective and there is no sign of this approach going away. Connecting Peers.

Media 52

Media Healthcare Healthcare Recruitment 52

PM360

AUGUST 26, 2024

Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. By sequencing the genomes of over 1,000 patients, they have identified 20 new ultra-rare genetic conditions. That’s how money is saved and quality of life (QOL) is improved. Bright Spots.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52